The domain of novel cell cytometers has attracted much attention of within the global biopharmaceutical industry in recent years. This popularity can be attributed mainly to the need of these tools to address the rising prevalence of chronic disease conditions. Cell cytometers allow for the simultaneous characterization of cells from a mixed population, thereby helping